What Researchers Did
Researchers prospectively studied 150 mechanically ventilated patients undergoing hyperbaric oxygen therapy over a 6-year period at a French university hyperbaric center to evaluate their epidemiology and tolerance.
What They Found
Of the 150 patients (11 children, 139 adults), carbon monoxide poisoning (51%) and iatrogenic gas embolism (33%) were the main reasons for intubation. Patient-ventilator asynchrony was the most frequent side effect, observed in 6 (5%) patients, often due to suboptimal sedation, and mortality was higher in patients with ARDS (23%).
What This Means for Canadian Patients
This study indicates that mechanical ventilation can be safely managed during hyperbaric oxygen therapy for conditions such as carbon monoxide poisoning or gas embolism. Canadian patients requiring this combined treatment may benefit from optimized sedation protocols to reduce complications like patient-ventilator asynchrony.
Canadian Relevance
The study was conducted in a French center with no direct Canadian connection. However, its findings on the safety and management of mechanically ventilated patients during hyperbaric oxygen therapy are relevant to similar clinical practices and patient care in Canada.
Study Limitations
The study was conducted at a single center in France, which may limit the generalizability of its findings to other hyperbaric centers or diverse patient populations.